Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Cardiology|February 7, 2002
[So-called "ampulla" cardiomyopathy associated with coronary vasospasm compared with acute myocardial infarction showing similar abnormal left ventricular wall motion: two case reports]Fumitaka Inoue, Makoto Takaoka, Hidetsugu Kumura, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|July 5, 2002
[Improvement of extrapulmonary lesions of eosinophilic granuloma after cessation of smoking]Akihiko Sudou, Toshio Hashimoto, Hiroyuki Nakamura, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|August 9, 2002
[Comparative study of bone resorption markers for the diagnosis of bone metastasis in lung cancer]Hiroyuki Nakamura, Syuji Oishi, Hisanaga Yagyu, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 21, 2018
Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1-3 fibrosisYuya Seko, Taichiro Nishikawa, Atsushi Umemura, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 27, 2020
Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 DiabetesMitsuyoshi Takahara, Toshihiko Shiraiwa, Taka-Aki Matsuoka, et al.
Hematological Oncology|February 9, 2019
Differential expression of estrogen receptor-α on follicular dendritic cells from patients with grade 1-2 and grade 3 follicular lymphomaRintaro Ohe, Hong-Xue Meng, Naing Ye Aung, et al.
Medical Oncology (Northwood, London, England)|November 1, 2008
A population-based study of gefitinib in patients with non-small cell lung cancerKenji Hayashibara, Hiroaki Satoh, Yoko Shinohara, et al.
Oncology Letters|February 20, 2013
Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancerTakayuki Kaburagi, Hiroaki Satoh, Kenji Hayashihara, et al.
Medical Oncology (Northwood, London, England)|November 3, 2012
Bevacizumab-containing chemotherapy for non-small cell lung cancer patients: a population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research groupHiroyuki Nakamura, Hiroaki Satoh, Takayuki Kaburagi, et al.
Molecular and Clinical Oncology|March 21, 2014
Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research GroupKoichi Kurishima, Hiroaki Satoh, Takayuki Kaburagi, et al.
Pageof 4